These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27601163)

  • 1. Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinoma.
    Jiang XM; Yu XN; Huang RZ; Zhu HR; Chen XP; Xiong J; Chen ZY; Huang XX; Shen XZ; Zhu JM
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2309-17. PubMed ID: 27601163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of eukaryotic translation initiation factor 4E and its clinical significance in hepatocellular carcinoma.
    Wang XL; Cai HP; Ge JH; Su XF
    World J Gastroenterol; 2012 May; 18(20):2540-4. PubMed ID: 22654452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival.
    Bouchagier KA; Assimakopoulos SF; Karavias DD; Maroulis I; Tzelepi V; Kalofonos H; Karavias DD; Kardamakis D; Scopa CD; Tsamandas AC
    In Vivo; 2014; 28(3):315-26. PubMed ID: 24815833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
    He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J
    Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
    Li B; Shao Q; Ji D; Li F; Guo X; Chen G
    Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
    Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
    Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of GOLM1 correlates with prognosis in human hepatocellular carcinoma.
    Chen MH; Jan YH; Chang PM; Chuang YJ; Yeh YC; Lei HJ; Hsiao M; Huang SF; Huang CY; Chau GY
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S616-24. PubMed ID: 23838921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.
    Ma M; Hua S; Li G; Wang S; Cheng X; He S; Wu P; Chen X
    Oncotarget; 2017 Feb; 8(8):12983-13002. PubMed ID: 28099905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LOXL4 is downregulated in hepatocellular carcinoma with a favorable prognosis.
    Tian M; Liu W; Jin L; Jiang X; Yang L; Ding Z; Shen Y; Peng Y; Gao D; Li L; Zhou J; Qiu S; Dai Z; Fan J; Shi Y
    Int J Clin Exp Pathol; 2015; 8(4):3892-900. PubMed ID: 26097573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.
    Yu L; Zhang J; Guo X; Li Z; Zhang P
    Cancer Epidemiol; 2014 Aug; 38(4):408-13. PubMed ID: 24923856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of OCT4 is associated with low differentiation and tumor recurrence in human hepatocellular carcinoma.
    Dong Z; Zeng Q; Luo H; Zou J; Cao C; Liang J; Wu D; Liu L
    Pathol Res Pract; 2012 Sep; 208(9):527-33. PubMed ID: 22824146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of CD112 is associated with poor overall survival in patients with hepatocellular carcinoma.
    Huang X; Qu P; Chen Y; Zhou X; Wu Y; Liu F; Wang D; Zhang J; An J
    Hum Pathol; 2014 Sep; 45(9):1944-50. PubMed ID: 25081539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage.
    Zhi Q; Zhu J; Guo X; He S; Xue X; Zhou J; Hu B; Li H; Chen S; Zhao H; Kuang Y
    Biomed Pharmacother; 2013 Jun; 67(5):393-8. PubMed ID: 23648054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mastermind-like Transcriptional Coactivator 1 Overexpression Predicts Poor Prognosis in Human with Hepatocellular Carcinoma.
    Wang J; Zhang SM; Wu JM; Lu ZC; Yang JR; Wu HS; Chen H; Lin B; Xu RH; Cao TS
    Ann Clin Lab Sci; 2016 Sep; 46(5):502-7. PubMed ID: 27650617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.